| scholarly article | Q13442814 |
| P2093 | author name string | G W Pasternak | |
| E F Hahn | |||
| M Carroll-Buatti | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 572-576 | |
| P577 | publication date | 1982-05-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines | |
| P478 | volume | 2 |
| Q34169931 | 14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile |
| Q28572514 | A naloxonazine sensitive (mu1 receptor) mechanism in the parabrachial nucleus modulates eating |
| Q48536754 | Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study |
| Q34482188 | Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration |
| Q44334506 | Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats |
| Q48231577 | Antinociceptive evaluation of 14β-(bromoacetamido)- 7,8-dihydro-N(cyclopropylmethyl)-normorphinone in mice |
| Q44334055 | Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor |
| Q73190576 | Antisense mapping: assessing functional significance of genes and splice variants |
| Q68275554 | Behavioural effects of deltorphins in rats |
| Q44349502 | Beta-funaltrexamine discriminates between two subtypes of mu2-opioid receptors in electrically stimulated longitudinal muscle of guinea pig ileum. |
| Q44336158 | Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actions |
| Q46916978 | Conformation and electrostatic potential surfaces of opiates: Relationship to µ- and λ-site binding. |
| Q37170275 | Development of delta opioid peptides as nonaddicting analgesics |
| Q44345097 | Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine |
| Q67275124 | Dissociation of morphine's analgesic and respiratory depressant actions |
| Q43921681 | Effects of adrenoceptor agonists and antagonists on morphine-induced Straub tail in mice |
| Q35025273 | Endomorphins and related opioid peptides |
| Q44351808 | Evidence that naloxonazine produces prolonged antagonism of central delta opioid receptor activity in vivo |
| Q47934009 | Genetic dissociation of morphine analgesia from hyperalgesia in mice |
| Q44345652 | Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy |
| Q48723027 | Mediation of insulin hyperphagia by specific central opiate receptor antagonists |
| Q44341747 | Micro1-opioid antagonist naloxonazine alters ethanol discrimination and consumption |
| Q33581970 | Mu opioid receptors in pain management |
| Q37236111 | Mu opioids and their receptors: evolution of a concept |
| Q48760480 | Multiple mu receptors: evidence for mu2 sites in the guinea pig ileum |
| Q44332990 | Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats |
| Q34253900 | Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites |
| Q52061969 | Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist. |
| Q44353172 | New opioid affinity labels containing maleoyl moiety |
| Q35049029 | Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence |
| Q40139515 | Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations and species differences |
| Q34250337 | Oxymorphazone: A long-acting opiate analgesic |
| Q34125112 | Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA. |
| Q52591971 | Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic. |
| Q34792671 | Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors |
| Q44342176 | Prolonged receptor blockade by opioid receptor probes |
| Q36064141 | Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude |
| Q44346265 | Pulsed magnetic field induced "analgesia" in the land snail, Cepaea nemoralis, and the effects of mu, delta, and kappa opioid receptor agonists/antagonists |
| Q44353461 | Specific μ2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine |
| Q44342170 | Synthesis and pharmacological characterization of fluorescent opioid receptor probes |
| Q34948489 | The N-terminally truncated µ3 and µ3-like opioid receptors are transcribed from a novel promoter upstream of exon 2 in the human OPRM1 gene |
| Q48739273 | The binding to rat brain homogenates of Mr2034, a universal opiate |
| Q67486592 | The role of mu1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse |
Search more.